Teva Begins Trading Ordinary Shares Directly on the NYSE, Marking a Milestone in its Pivot to Growth Strategy

Positive

AI Analysis

Summary

Teva Pharmaceutical Industries completed the transition of its ordinary shares to direct trading on the NYSE under ticker TEVA, replacing its previous ADS structure as part of its Pivot to Growth strategy.

Importance:3/10

Sentiment:

0.30

stock_listingNYSEADS_transitioncorporate_reorganization

Related Companies

$TEVA

Read the original article

Published by GlobeNewswire Pharma on September 14, 2026 12:03 PM

Read Original